Nitroaspirin

DB12445InvestigationalSmall molecule

Nitroaspirin has been investigated for the treatment of Intermittent Claudication.

Chemical structure of Nitroaspirin
Mechanism
Curator reviewed
Formula / weight
C16H13NO7 · 331.28 g/mol (avg)
Code names
NCX-4016

Resolves to

Compound
UNIIEH04H13L6BCAS175033-36-0ChEMBLCHEMBL374385ChEBI125482PubChem119032
Structure
InChIKeyIOJUJUOXKXMJNF-UHFFFAOYSA-NSMILESCC(=O)OC1=CC=CC=C1C(=O)OC1=CC=CC(CO[N+]([O-])=O)=C1
Targets
P23219PTGS1P35354PTGS2

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1,617Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Nitroaspirin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In